The reliability and validity of lung cancer and melanoma clinical quality survival measures.

ABSTRACT:

Objective

To develop a risk adjustment approach and test reliability and validity for oncology survival measures.

Data sources and study setting

We used the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER)-Medicare data from 2010 to 2013, with mortality data through 2015.

Study design

We developed 2-year risk-standardized survival rates (RSSR) for melanoma, non-small cell lung cancer (NSCLC), and small cell lung cancer (SCLC). Patients were attributed to group practices based on the plurality of visits. We identified the risk-adjustment variables via bootstrap and calculated the RSSRs. Reliability was tested via three approaches: (1) signal-to-noise ratio (SNR) reliability, (2) split-half, and (3) test-retest using bootstrap. We tested kn

SUBMITTER: Pendl-Robinson E 

PROVIDER: S-EPMC10480076 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature